Lv72
4300 积分 2022-09-13 加入
中国药物性肝损伤诊治指南（2023年版）
14天前
已完结
中国药物性肝损伤基层诊疗与管理指南（2024年）
14天前
已完结
Identification and validation of INHBE and P4HA1 as hub genes in non-alcoholic fatty liver disease
1个月前
已完结
中国超重/肥胖不孕不育患者体质量管理路径与流程专家共识
4个月前
已完结
急性ST段抬高型心肌梗死诊断和治疗指南
4个月前
已完结
现代战伤救治的新概念和新策略
5个月前
已完结
Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial
5个月前
已完结
Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial
5个月前
已完结
A Bioinspired Lipopeptide Surmounts Therapeutic Dilemmas of Gram-Positive and Gram-Negative Polymicrobial Infection
7个月前
已完结
中华内分泌代谢杂志
9个月前
已完结
皖公网安备34019202002308
